 | • レポートコード：TPM-C02135 • 出版社/出版日：Transparency Market Research / 2018年11月21日 • レポート形態：英文、PDF、172ページ • 納品方法：Eメール • 産業分類：Pharmaceutical |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ボツリヌス毒素の世界市場について調べ、ボツリヌス毒素の世界規模、市場動向、市場環境、製品タイプ別（ボツリヌス毒素A型およびボツリヌス毒素B型）分析、用途（審美、治療）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・ボツリヌス毒素の世界市場動向 ・ボツリヌス毒素の世界市場環境 ・ボツリヌス毒素の世界市場規模 ・ボツリヌス毒素の世界市場規模：製品タイプ別（ボツリヌス毒素A型およびボツリヌス毒素B型） ・ボツリヌス毒素の世界市場規模：用途（審美、治療） ・ボツリヌス毒素の世界市場：地域別市場規模・分析 ・ボツリヌス毒素の北米市場規模・予測 ・ボツリヌス毒素のアメリカ市場規模・予測 ・ボツリヌス毒素の中南米市場規模・予測 ・ボツリヌス毒素のヨーロッパ市場規模・予測 ・ボツリヌス毒素のアジア市場規模・予測 ・ボツリヌス毒素の日本市場規模・予測 ・ボツリヌス毒素の中国市場規模・予測 ・ボツリヌス毒素のインド市場規模・予測 ・ボツリヌス毒素の中東市場規模・予測 ・ボツリヌス毒素のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Botulinum Toxin Market: Overview
This report analyzes the current and future scenario of the global botulinum toxin market. Botulinum toxin is a neurotoxin that is produced by the bacterium clostridium botulinum. There are around eight types of botulinum toxins A-H, produced by the bacterium. Botulinum toxin type A is capable of causing diseases in humans; however, it is widely utilized commercially and medically for the treatment of several aesthetic diseases such as glabellar lines, crow’s foot, and face and forehead wrinkles. Botulinum toxin is also utilized in the therapeutic treatment of spasticity, cervical dystonia, and migraine. Botulinum toxin procedure is a non-surgical cosmetic procedure that is noninvasive or minimally invasive in nature. Botulinum toxin procedure is a non-surgical and noninvasive or minimally invasive and has several advantages, such as no downtime, less time of surgery, no need of hospitalization, and faster recovery, over conventional cosmetic or aesthetic surgeries.
The global botulinum toxin market is expanding at a high pace owing to the increase in prevalence of cervical dystonia and upper limb and lower limb spasticity. Rise in global geriatric population and adoption of new non-surgical aesthetic procedures is fuelling the market. Growing incidences of glabellar lines, face and forehead wrinkles, and crow’s foot and consistent worldwide rise in cases of migraine are boosting the market. Furthermore, rising number of skilled professionals performing non-surgical botulinum toxin procedures, favorable government regulations regarding the commercial usage of botulinum toxins, and advantages of faster onset of action of botulinum toxin procedure over traditional cosmetic procedure are propelling the botulinum toxin market.
This report on the global botulinum toxin market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on product type, application, and region. A detailed qualitative analysis of drivers, restraints, opportunities and trends of the market has been provided in the overview section. Additionally, the market outlook section offer key insights of the global market such as price comparison analysis, pipeline analysis and launch & patent expiry snapshot. It also provides market attractiveness analysis, in terms of region and key strategies adopted by players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global botulinum toxin market.
Global Botulinum Toxin Market: Key Segments
Botulinum toxin market has segmented into product type, application, and region. Based on product type, the botulinum toxin market has been classified into botulinum toxin type A and botulinum toxin type B. Based on application, the market has been bifurcated into aesthetic and therapeutics, which are the main application areas of the market. Each of the segments has been analyzed in detail in terms of market trends, recent developments, drivers, restraints, opportunities, and useful insights. The report gives current and future market size for each segment and sub-segment of the market for the period of 2018 to 2026, in terms of revenue depicted in US$ Mn, considering 2017 as the base year and 2016 as the historical year. The compound annual growth rate (CAGR) has been provided for each segment and the overall market for the period of 2018 to 2026, along with market size estimations.
Global Botulinum Toxin Market: Regional Outlook
In terms of region, the global botulinum toxin market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further sub-segmented into major countries and sub-regions. The current and future market size, in terms of value, of the botulinum toxin market at the regional and country level has been provided in the report for the period of 2016 to 2026, along with their growth rate in percentage for the period of 2018 to 2026. The study also provides useful insights of the market, expected to help new companies willing to enter the market and existing companies seeking to increase their market share.
Companies Mentioned in the Report
The report profiles major companies operating in the global botulinum toxin market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, recent developments, and SWOT (strength, weakness, opportunity, and threat) analysis. Major companies mentioned are Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc. (US), Lanzhou Institute of Biological Products Co. Ltd., and Revance Therapeutics, Inc.
The global botulinum toxin market has been segmented as follows:
Global Botulinum toxin Market, by Product Type
Botulinum Toxin Type A
Botulinum Toxin Type B
Global Botulinum toxin Market, by Application
Aesthetic
Therapeutics
Global Botulinum toxin Market, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Botulinum Toxin Market
4. Market Overview
4.1. Introduction
4.1.1. by Product Type Definition
4.1.2. Market Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increasing demand for minimally invasive and non-invasive aesthetic and therapeutic procedures
4.3.1.2. Increase in prevalence of spasticity and cervical dystonia
4.3.1.3. Increasing number of products approval and new product launch in different region
4.3.1.4. Rising awareness regarding botulinum toxin procedures in the geriatric population worldwide
4.3.2. Restraints
4.3.2.1. Short time results and repetitive nature of aesthetic and therapeutic procedures
4.3.2.2. High cost of procedures and unavailability of reimbursement policies
4.3.3. Opportunities
4.3.3.1. Use of botulinum toxin products for the treatment of migraine and over sweating
4.3.3.2. Numerous products in phase III and above clinical trials for various disease conditions
4.4. Global Botulinum Toxin Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Price Comparison Analysis (2017)
5.2. Pipeline Analysis
5.3. Launch and Patent Expiry – Snapshot
5.4. Key Trends
5.4.1. Increasing use of botulinum toxin aesthetic treatments by men
5.4.2. New and improved approaches regarding formulation types and delivery of botulinum toxin products
6. Global Botulinum Toxin Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
6.3.1. Botulinum Toxin Type A
6.3.2. Botulinum Toxin Type B
6.4. Market Attractiveness by Product Type
7. Global Botulinum Toxin Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Botulinum Toxin Market Value Forecast, by Application, 2016–2026
7.3.1. Aesthetic
7.3.2. Therapeutics
7.4. Global Botulinum Toxin Market Attractiveness, by Application
8. Global Botulinum Toxin Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Botulinum Toxin Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Botulinum Toxin Market Attractiveness, by Region
9. North America Botulinum Toxin Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
9.2.1. Botulinum Toxin Type A
9.2.2. Botulinum Toxin Type B
9.3. North America Botulinum Toxin Market Value Forecast, by Application, 2016–2026
9.3.1. Aesthetic
9.3.2. Therapeutics
9.4. North America Botulinum Toxin Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. North America Botulinum Toxin Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Application
9.5.3. By Country
10. Europe Botulinum Toxin Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
10.2.1. Botulinum Toxin Type A
10.2.2. Botulinum Toxin Type B
10.3. Europe Botulinum Toxin Market Value Forecast, by Application, 2016–2026
10.3.1. Aesthetic
10.3.2. Therapeutics
10.4. Europe Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Botulinum Toxin Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Application
10.5.3. By Country/Region
11. Asia Pacific Botulinum Toxin Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
11.2.1. Botulinum Toxin Type A
11.2.2. Botulinum Toxin Type B
11.3. Asia Pacific Botulinum Toxin Market Value Forecast, by Application, 2016–2026
11.3.1. Aesthetic
11.3.2. Therapeutics
11.4. Asia Pacific Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Rest of Asia Pacific
11.5. Asia Pacific Botulinum Toxin Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Application
11.5.3. By Country/Region
12. Latin America Botulinum Toxin Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
12.2.1. Botulinum Toxin Type A
12.2.2. Botulinum Toxin Type B
12.3. Latin America Botulinum Toxin Market Value Forecast, by Application, 2016–2026
12.3.1. Aesthetic
12.3.2. Therapeutics
12.4. Latin America Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Botulinum Toxin Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Botulinum Toxin Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
13.2.1. Botulinum Toxin Type A
13.2.2. Botulinum Toxin Type B
13.3. Middle East & Africa Botulinum Toxin Market Value Forecast, by Application, 2016–2026
13.3.1. Aesthetic
13.3.2. Therapeutics
13.4. Middle East & Africa Botulinum Toxin Market Value Forecast, by Country/Region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Botulinum Toxin Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by Tier and Size of companies)
14.2. Market Share Analysis by Company (2017)
14.3. Company Profiles
14.3.1. Allergan, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Ipsen Group
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Medytox, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Merz Pharma GmbH & Co. KGaA
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. US Worldmed, LLC
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.6. Nestlé Skin Health (Galderma)
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Metabiologics, Inc. (US)
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.8. Hugel Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Lanzhou Institute of Biological Products Co. Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Revance Therapeutics, Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
Table 01: Global Botulinum Toxin Market: Pipeline Analysis
Table 02: Global Botulinum Toxin Market: Price Comparison Analysis
Table 03: Global Botulinum Toxin Market: Launch Snapshot
Table 04: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 05: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 06: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 07: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 08: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 09: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 10: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 11: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 12: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 13: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 14: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 15: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 16: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 17: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 19: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 20: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 21: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 22: Pipeline Products - Allergan plc
Table 23: Pipeline Products - Ipsen Pharma
Table 24: Pipeline Products - Medytox Inc.
Table 25: Pipeline Products - US Worldmed, LLC
Table 26: Pipeline Products - Revance Therapeutics, Inc.